A Study to Assess Symptom Burden in Subjects With Nonmyeloid Malignancies Receiving Chemotherapy and Aranesp®
Clinical trial NCT00117117 · COMPLETED
Trial details
- NCT number
- NCT00117117
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2002-09-01
- Enrollment
- 2423
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.